(Q51976505)

19 April 2018

title

Comparison of preferences for health outcomes in schizophrenia among stakeholder groups. (English)

1 reference

19 April 2018

1 reference

Lee TT

1

1 reference

19 April 2018

Ziegler JK

2

1 reference

19 April 2018

Sommi R

3

1 reference

19 April 2018

Sugar C

4

1 reference

19 April 2018

Mahmoud R

5

1 reference

19 April 2018

Lenert LA

6

1 reference

19 April 2018

publication date

1 May 2000

1 reference

19 April 2018

Journal of Psychiatric Research

published in

1 reference

19 April 2018

volume

34

1 reference

19 April 2018

issue

3

1 reference

19 April 2018

page(s)

201-210

1 reference

19 April 2018

Negative v positive schizophrenia. Definition and validation.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900009-1

Economic and health state utility determinations for schizophrenic patients treated with risperidone or haloperidol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900009-1

A clinician's guide to cost-effectiveness analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900009-1

Subjective utility ratings of neuroleptics in treating schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900009-1

The new technology assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900009-1

The positive and negative syndrome scale (PANSS) for schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900009-1

Measurement of the validity of utility elicitations performed by computerized interview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900009-1

Automated computer interviews to elicit utilities: potential applications in the treatment of deep venous thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900009-1

Effects on preferences of violations of procedural invariance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900009-1

Risperidone in the treatment of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900009-1

On the elicitation of preferences for alternative therapies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900009-1

The utility of different health states as perceived by the general public

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900009-1

Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900009-1

Quality-of-life research on the Internet: feasibility and potential biases in patients with ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900009-1

Measurement of health state utilities for economic appraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900009-1

Foundations of Cost-Effectiveness Analysis for Health and Medical Practices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900009-1

Methodological issues of patient utility measurement. Experience from two clinical trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900009-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3956(00)00009-1

1 reference

19 April 2018

PubMed ID

10867115

1 reference

19 April 2018